Home> Products> personalized regimen q6

{ "products": [ { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G 0.5 FORTE", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-07-24T12:57:55.385Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "glimepiride and metformin hydrochloride tablets", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642d09ccd5ce1a1075bbfe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LT PRIDE 25", "description": "LT PRIDE 25\nLevosulpiride (25mg)\nLT Pride 25 contains Levosulpiride (25mg), a medication used primarily to treat psychiatric disorders and gastrointestinal issues. Levosulpiride is a dopamine receptor antagonist that acts on the central and peripheral nervous systems.\n\nIn psychiatric conditions, Levosulpiride is often prescribed for:\n\nDepressive Disorders: It may help improve mood and reduce symptoms of depression.\nAnxiety Disorders: Levosulpiride can be used as an adjunctive treatment to manage anxiety symptoms.\nSchizophrenia and Psychotic Disorders: It may help control symptoms such as hallucinations and delusions.\nIn gastrointestinal conditions, Levosulpiride is used to:\n\nFunctional Dyspepsia: It helps relieve symptoms like bloating, nausea, and early satiety by regulating gastric motility.\nGastroesophageal Reflux Disease (GERD): Levosulpiride can reduce reflux symptoms and improve esophageal motility.\nIrritable Bowel Syndrome (IBS): It may alleviate symptoms such as abdominal pain and altered bowel habits.\nLevosulpiride works by blocking dopamine receptors, which can modulate neurotransmitter levels in the brain and regulate gastrointestinal motility. It is important to take Levosulpiride as prescribed by a healthcare professional, as dosage and duration of treatment vary based on the condition being treated.\n\nCommon side effects of Levosulpiride may include drowsiness, dizziness, gastrointestinal disturbances, and hormonal changes. It is not recommended for use in certain conditions such as Parkinson's disease, pheochromocytoma, or hypersensitivity to the drug.\n\nAlways consult with your doctor before starting or adjusting any medication regimen, as they can provide personalized guidance based on your medical history and current health status.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lt-pride-25-133776\n\n\n\n\n\n\n", "price": 99.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBS", "GERD", "Call", "mood", "25mg", "drug", "Email", "brain", "doctor", "dosage", "nausea", "central", "bloating", "WhatsApp", "LT PRIDE", "duration", "delusions", "Parkinson", "dizziness", "drowsiness", "depression", "information", "sterispharma", "bowel habits", "sterisonline", "Levosulpiride", "early satiety", "Schizophrenia", "hallucinations", "abdominal pain", "reflux symptoms", "medical history", "pheochromocytoma", "hypersensitivity", "gastric motility", "anxiety symptoms", "hormonal changes", "Anxiety Disorders", "dopamine receptors", "medication regimen", "Psychotic Disorders", "Common side effects", "esophageal motility", "adjunctive treatment", "Functional Dyspepsia", "Depressive Disorders", "personalized guidance", "psychiatric disorders", "current health status", "psychiatric conditions", "healthcare professional", "neurotransmitter levels", "gastrointestinal issues", "Irritable Bowel Syndrome", "gastrointestinal motility", "peripheral nervous systems", "gastrointestinal conditions", "dopamine receptor antagonist", "gastrointestinal disturbances", "Gastroesophageal Reflux Disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1570, "imageuri": "https://productimages.withfloats.com/actual/66642d0b0b1c30627459efc2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66642d0b0b1c30627459efc2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:06:01.299Z", "updatedon": "2024-06-28T09:30:13.753Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lt-pride-25/1570", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LT PRIDE 25", "category": "GASTROLOGYRANGE", "tags": [ "LT PRIDE 25", "Levosulpiride (25mg)", "Levosulpiride 25mg in Hindi", "Levosulpiride side effects", "Levosulpiride 25 mg brand name", "Levosulpiride 25 mg Tablet price", "Levosulpiride dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662cb712bed1f08484d6d9c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ANASTRAZONE 1 ", "description": "ANASTRAZONE 1\nAnastrozole lp (1mg) \nAnastrozole 1 is a medication containing Anastrozole LP, with each tablet containing 1mg of the active ingredient. Anastrozole is classified as an aromatase inhibitor and is commonly prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Here are key points about Anastrazone 1:\n\nMechanism of Action: Anastrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens. By reducing estrogen levels in the body, Anastrozole helps in slowing down or stopping the growth of hormone-sensitive tumors.\n\nIndications: Anastrazone 1 is indicated for the adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women. It may also be used in the treatment of advanced breast cancer in postmenopausal women who have not responded well to tamoxifen or other anti-estrogen therapies.\n\nDosage and Administration: The usual recommended dose of Anastrazone 1 is 1mg orally once daily, with or without food. It is important to follow the prescribed dosage and schedule as directed by your healthcare provider.\n\nSide Effects: Common side effects of Anastrazone 1 may include hot flashes, joint pain, headache, nausea, and weakness. Serious side effects such as bone fractures, cardiovascular events, and liver problems are rare but may occur.\n\nPrecautions: Before starting Anastrazone 1, inform your healthcare provider about any existing medical conditions, especially liver disease or osteoporosis. Regular monitoring of bone density and liver function may be recommended during treatment.\n\nDrug Interactions: Anastrazone 1 may interact with certain medications, including estrogen-containing products, tamoxifen, and some cholesterol-lowering drugs. Inform your doctor about all medications, supplements, and herbal products you are taking.\n\nPregnancy and Lactation: Anastrazone 1 is contraindicated during pregnancy and breastfeeding. It may cause harm to the unborn baby or nursing infant. Use effective contraception during treatment with Anastrazone 1 if you are of childbearing age.\n\nStorage: Store Anastrazone 1 at room temperature away from moisture and heat. Keep it out of reach of children and pets.\n\nAlways consult your healthcare provider for personalized guidance and information specific to your medical condition and treatment regimen.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/anastrazone-1-133889", "price": 429.0, "discountamount": 129.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1mg", "Call", "body", "pets", "heat", "food", "harm", "Order", "Email", "reach", "growth", "Dosage", "nausea", "tablet", "doctor", "infant", "Storage", "moisture", "WhatsApp", "weakness", "headache", "schedule", "children", "Pregnancy", "Mechanism", "androgens", "estrogens", "Lactation", "tamoxifen", "medication", "key points", "joint pain", "Indications", "information", "Precautions", "supplements", "ANASTRAZONE", "unborn baby", "hot flashes", "osteoporosis", "sterisonline", "bone density", "breastfeeding", "liver disease", "liver function", "bone fractures", "Anastrozole LP", "liver problems", "Administration", "herbal products", "estrogen levels", "enzyme aromatase", "childbearing age", "room temperature", "active ingredient", "Drug Interactions", "treatment regimen", "Regular monitoring", "adjuvant treatment", "aromatase inhibitor", "Common side effects", "healthcare provider", "Serious side effects", "postmenopausal women", "cardiovascular events", "personalized guidance", "usual recommended dose", "advanced breast cancer", "effective contraception", "hormone-sensitive tumors", "cholesterol-lowering drugs", "existing medical conditions", "estrogen-containing products", "other anti-estrogen therapies", "early hormone receptor-positive breast cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1517, "imageuri": "https://productimages.withfloats.com/actual/667d31e6576e8da931df6df3.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d31e6576e8da931df6df3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:57:21.017Z", "updatedon": "2024-06-27T09:33:24.204Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/anastrazone-1-/1517", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ANASTRAZONE 1 ", "category": "GENERAL RANGE", "tags": [ "anastrozole 1 mg tablet uses", "anastrozole 1 mg tablet brand name", "anastrozole 1 mg tablet uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665efaa48ecffe165c350b61", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA TENE 10/20 ", "description": "GLIDAPA TENE 10/20 \nDapagliflozin & Teneligliptin\nIntroduction\nGLIDAPA TENE 10/20 is a cutting-edge oral medication engineered for the management of Type 2 diabetes. This combination therapy includes Dapagliflozin (10 mg) and Teneligliptin (20 mg), two powerful drugs that work synergistically to control high blood sugar levels effectively.\n\nHow It Works\n\nDapagliflozin (10 mg): Dapagliflozin belongs to the class of drugs known as SGLT2 inhibitors. It works by preventing the kidneys from reabsorbing glucose back into the blood, promoting the excretion of glucose through urine. This leads to a reduction in blood glucose levels and can also aid in weight loss and blood pressure control.\nTeneligliptin (20 mg): Teneligliptin is a DPP-4 inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing the release of insulin and decreasing the release of glucagon after meals. This helps to smooth out blood sugar spikes that can occur post-meal.\nBenefits\nGLIDAPA TENE 10/20 offers a comprehensive approach to diabetes management by targeting different pathways in glucose metabolism. The combination of Dapagliflozin and Teneligliptin provides a dual mechanism of action, which can be more effective in lowering blood glucose levels compared to monotherapy. This can also lead to improvements in HbA1c levels, a key indicator of long-term glycemic control.\n\nDosage and Administration\n\nDosage: The standard dosage is one tablet per day, but it should be adjusted based on the patient's specific medical condition, tolerance, and the effectiveness of the treatment.\nAdministration: GLIDAPA TENE 10/20 should be taken in the morning with or without food. Consistent daily intake helps maintain stable drug levels in the blood and ensures maximum efficacy.\nSide Effects\nThe most common side effects associated with GLIDAPA TENE 10/20 may include urinary tract infections due to the increased glucose in urine, and gastrointestinal disturbances such as nausea or constipation. Patients may also experience a slight risk of dehydration and should be advised to maintain adequate fluid intake.\n\nConclusion\nGLIDAPA TENE 10/20 is an innovative medication for managing Type 2 diabetes, providing potent dual-action control over high blood sugar levels. It simplifies the treatment regimen by combining two effective medications into a single daily dose, potentially enhancing patient compliance and improving overall diabetes management. As always, patients should consult their healthcare provider for personalized advice and to adjust the treatment plan as needed to achieve optimal health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-tene-10-20-134223", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "meals", "urine", "Order", "class", "EMAIL", "nausea", "insulin", "morning", "release", "kidneys", "Patients", "glucagon", "Benefits", "excretion", "reduction", "tolerance", "Conclusion", "one tablet", "slight risk", "dehydration", "weight loss", "information", "monotherapy", "Introduction", "GLIDAPA TENE", "sterisonline", "HbA1c levels", "improvements", "constipation", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "key indicator", "dual mechanism", "treatment plan", "standard dosage", "Type 2 diabetes", "DPP-4 inhibitor", "natural ability", "maximum efficacy", "SGLT2 inhibitors", "single daily dose", "treatment regimen", "different pathways", "two powerful drugs", "glucose metabolism", "stable drug levels", "blood sugar spikes", "patient compliance", "personalized advice", "common side effects", "healthcare provider", "combination therapy", "blood glucose levels", "Teneligliptin (20 mg", "innovative medication", "Administration Dosage", "adequate fluid intake", "comprehensive approach", "blood pressure control", "optimal health outcomes", "high blood sugar levels", "Consistent daily intake", "urinary tract infections", "two effective medications", "specific medical condition", "long-term glycemic control", "potent dual-action control", "overall diabetes management", "gastrointestinal disturbances", "cutting-edge oral medication engineered" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1296, "imageuri": "https://productimages.withfloats.com/actual/665efaa8d93d0ca61a4976f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efaa8d93d0ca61a4976f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:29:40.684Z", "updatedon": "2024-06-04T11:29:40.684Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-tene-10-20-/1296", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENE 10/20 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f38987594971b42f56f7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CITICOTIME PM", "description": "CITICOTIME PM is a clinically advanced neuroprotective tablet that combines two well-researched components: Citicoline 500mg and Piracetam 800mg. This powerful formulation is tailored to support brain function and facilitate neurological recovery, particularly beneficial for patients recovering from strokes or dealing with cognitive issues. Citicoline enhances brain metabolism and aids in nerve cell membrane repair, while Piracetam improves neural communication and boosts neuroplasticity. Together, they offer a comprehensive approach to protecting and enhancing brain health. CITICOTIME PM is ideal for patients undergoing neurorehabilitation or looking to manage memory and cognitive deterioration as part of a prescribed regimen.\n\nWhat Are Citicoline and Piracetam Tablets?\nCITICOTIME PM delivers Citicoline and Piracetam in a tablet form, with each dose containing 500mg of Citicoline and 800mg of Piracetam. Citicoline supports the repair of damaged neurons and strengthens cell membrane integrity, while Piracetam stimulates neurotransmission, enhances memory and attention, and promotes cognitive function. This combination works synergistically to facilitate brain recovery following neurological injuries such as strokes.\n\nUses of Citicoline and Piracetam Tablets\nAssists in post-stroke treatment and neurological rehabilitation\n\nPrescribed for memory loss or age-related cognitive impairment\n\nBeneficial for patients with Alzheimer's disease, vascular dementia, or mild cognitive decline\n\nSupports recovery after traumatic brain injuries\n\nPromotes neuroregeneration and cognitive health\n\nDosage Guidelines\nThe standard recommended dose of CITICOTIME PM is one tablet daily or twice daily, as directed by your healthcare provider. Dosage may vary depending on the patient’s condition, tolerance level, and medical history. Always follow your doctor's advice for the safest and most effective results.\n\nPossible Side Effects\nWhile CITICOTIME PM is generally well-tolerated, some individuals may experience side effects such as:\n\nHeadaches\n\nDifficulty sleeping (insomnia)\n\nNausea or digestive discomfort\n\nIrritability or restlessness\n\nDizziness\n\nSkin rashes or allergic reactions (rare)\n\nSlight increase in blood pressure (rare)\n\nIf symptoms persist or worsen, consult a medical professional promptly.\n\nPrecautions Before Use\nBefore starting CITICOTIME PM, let your doctor know if you:\n\nHave any known allergies to Citicoline, Piracetam, or related drugs\n\nSuffer from kidney or liver disorders, bleeding problems, or psychiatric conditions\n\nAre pregnant, planning to become pregnant, or breastfeeding\n\nAre elderly or managing chronic health conditions\n\nAre consuming alcohol or other CNS depressants\n\nDrug Interactions\nCITICOTIME PM may interact with certain medications, including:\n\nBlood thinners (e.g., warfarin) – may increase bleeding risk\n\nCNS stimulants – may intensify neurological effects\n\nAntiepileptics (e.g., phenytoin, carbamazepine) – may require dose adjustments\n\nAlways inform your physician of all medications and supplements you are using to avoid potential adverse interactions.\n\nConclusion\nCITICOTIME PM is a scientifically backed formulation combining Citicoline 500mg and Piracetam 800mg, aimed at enhancing cognitive abilities and supporting neurological recovery. It’s particularly effective in post-stroke management, age-related memory loss, and other cognitive impairments. With proper medical supervision, this combination offers significant improvement in focus, memory, and brain performance. Always follow your doctor’s recommendations for optimal safety and benefits.", "price": 529.0, "discountamount": 159.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2157, "imageuri": "https://productimages.withfloats.com/actual/6891f390290a9ac19683599a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f390290a9ac19683599a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:05:29.796Z", "updatedon": "2025-08-05T12:05:29.796Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/citicotime-pm/2157", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Citicoline and piracetam tablets", "category": "NEUROLOGY RANGE", "tags": [ "Citicoline and piracetam tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 25", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2025-06-02T12:31:28.199Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25 mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }